Taiho Pharmaceutical

Jan 20, 2018

Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium

Jan 12, 2018

Taiho Oncology Announces Multiple LONSURF® (trifluridine and tipiracil) Presentations at ASCO 2018 Gastrointestinal Cancers Symposium

Jan 08, 2018

STORM Therapeutics Extends Series A Round to Include New Investor Taiho Ventures

Jan 03, 2018

Taiho Oncology Names Timothy Whitten President

Oct 20, 2017

Health Canada Grants Priority Review Status to trifluridine and tipiracil for Refractory Metastatic Colorectal Cancer

May 30, 2017

Innovative Patient Registry to Provide Important Insights into the "Real World" Management of Metastatic Colorectal Cancer